Biggest News Aggregation in the World
📰 Dc News

Page 180 - Dc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dc. Real-time updates on events, politics, business and more.

Mucormycosis and Mitigating Infection Risks to Protect Patients, Workers and Building Occupants

Mucormycosis is a rare but serious type of fungal infection caused by a group of fungi known as mucormycetes. Mucor species and Rhizopus species are some of the most common causes of mucormycosis, however there are also other species. The fungi typically live in soil and decaying organic matter., , , , It is frequently a life-threatening infection warns the Centers for Disease Control and Prevention (CDC). The agency also cautions that while most cases of mucormycosis are sporadic, outbre....
Paul Cochrane Clark Seif Derricka Denis Cochrane Associates Program Industrial Hygienist Centers For Disease

'Garbage In Is Garbage Out': Why Healthcare AI Models Can Only Be As Good As The Data They're Trained On

When developing or deploying new algorithms, hospitals and healthcare AI developers must pay close attention to the quality of training datasets, as well as take active steps to mitigate biases, said Divya Pathak, chief data officer at NYC Health + Hospitals, during a recent panel.
United States New York Divya Pathak Reuters Events New York City Weight Loss

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

AstraZeneca's Rare Disease Pipeline Notches Another FDA Approval

The FDA approved AstraZeneca drug Voydeya as an add-on to standard therapies for paroxysmal nocturnal hemoglobinuria, a rare blood disorder. Alexion, now AstraZeneca’s rare disease subsidiary, added the small molecule to its pipeline via a 2019 acquisition.
Amolyt Pharma Alexion Pharmaceuticals Achillion Pharmaceuticals Lancet Haematology Astrazeneca Rare Disease Weight Loss

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science